Number of pages: 100-120 | Report Format: PDF | Published date: 18 March, 2020
Historical Years – 2018 & 2019 | Base Year – 2020 | Forecasted Years – 2021 to 2031
Biobank is a repository that is responsible for the collection, processing, analyzing, management, and storage of biological samples. Biobanks have samples of human as well as non-human origin, such as infected tissues, bacterial, viral, or several other types of samples. The most common types of samples donated in biobanks are blood and urine. Samples stored in biobanks are used for research studies as well as for the development of new treatments & technologies.
Biological samples or biospecimens have been collected and stored in bio-repositories for decades. The field of biobanking has tremendously changed over the past few years. Initially, these repositories were managed manually however nowadays modernized automated facilities are managing these bio-samples. There are several types of biobanks such as disease-centric, genetic or DNA/RNA, population-based, project-driven, commercial, virtual biobanks, among others.
Increasing number of research activities in the field of rare diseases, cancers, personalized medicine, among others are playing a major role in propelling the market growth. Increasing initiatives such as collaborations and rising public-private funding for research activities are also contributing to the growth of biobanking market globally. However, higher cost of equipment required for storing samples is one of the factors hindering the market growth to a certain extent.
The global biobanking market has been analyzed from five perspectives: Products & Services, Sample Type, Application, Storage Type, and Region.
Biobanking Market by Products & Services
Based on products & services, the biobanking market has been segmented into equipment, consumables, software, and services. Equipment segment is further categorized into sample processing equipment, sample analysis equipment, storage equipment, and sample transport equipment. Consumables segment is further categorized into collection consumables, processing consumables, analysis consumables, and storage consumables. The services segment is further categorized into sample collection services, sample processing services, sample analysis services, sample storage services, and sample transport services. Equipment segment dominated the products & services segment in 2019. Several factors such as the increasing number of biobanks globally, increasing technological advancements, and new product launches have played a key role in driving the growth of this segment.
Biobanking Market by Sample Type
Based on the sample type, the market has been segmented into biological fluids, cell lines, human tissue nucleic acids, and others. The biological fluids segment held the largest share in this segment owing to the increasing number of sample collections such as blood & blood products, as these are used for the separation of DNA and RNA.
Biobanking Market by Application
Based on the application, the market has been segmented into regenerative medicine and research. The regenerative medicine segment held the largest share in the application segment. Increasing research in the field of regenerative medicine and rising private & public funding for stem cell research is the major factor driving its growth.
Biobanking Market by Region
Based on the region, the global biobanking market has been segmented into North America, Europe, Asia Pacific, and the Rest of the World (RoW). Europe held substantial market share in the global biobanking market. Factors such as the increasing number of research studies and rising funding for research activities are playing a pivotal role in boosting the European biobanking market. Moreover, biobanks in this region are collaborating with companies or organizations or institutes to carry out various projects. For instance, in Dec 2020, UK Biobank collaborated with a consortium of ten biopharmaceutical companies to study plasma proteome. According to UK Biobank, the Pharma Proteomics Project is anticipated to be one of the world's largest studies of blood protein concentrations conducted to date. The Project aims to significantly enhance the field of proteomics, by enabling better understanding of disease processes and supporting innovative drug development. Ten leading biopharmaceutical companies including Amgen, AstraZeneca, Biogen, Bristol Myers Squibb, Genentech (Roche), GlaxoSmithKline (GSK), The Janssen Pharmaceutical Companies (Johnson & Johnson), Pfizer Inc., Regeneron, and Takeda Pharmaceutical Co. Ltd. are commissioning and funding the study.
Some of the prominent players operating in the global biobanking market includes:-